During the last session, MediWound Ltd. (NASDAQ:MDWD)’s traded shares were 0.32 million, with the beta value of the company hitting 1.53. At the end of the trading day, the stock’s price was $3.12, reflecting an intraday gain of 5.76% or $0.17. The 52-week high for the MDWD share is $6.22, that puts it down -99.36 from that peak though still a striking 29.49% gain since the share price plummeted to a 52-week low of $2.20. The company’s market capitalization is $88.98M, and the average trade volume was 110.03K shares over the past three months.
MediWound Ltd. (MDWD) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 1.70. MDWD has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 6 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.15.
3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
MediWound Ltd. (MDWD) registered a 5.76% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 5.76% in intraday trading to $3.12 this Friday, 01/07/22, hitting a weekly high. The stock’s 5-day price performance is 32.20%, and it has moved by 27.35% in 30 days. Based on these gigs, the overall price performance for the year is -23.90%.
The consensus price target of analysts on Wall Street is $6.92, which implies an increase of 54.91% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6.00 and $9.00 respectively. As a result, MDWD is trading at a discount of -188.46% off the target high and -92.31% off the low.
MediWound Ltd. (MDWD) estimates and forecasts
Statistics show that MediWound Ltd. has underperformed its competitors in share price, compared to the industry in which it operates. MediWound Ltd. (MDWD) shares have gone down -27.27% during the last six months, with a year-to-date growth rate less than the industry average at -44.12% against 16.80. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -150.00% this quarter and then drop -60.00% in the quarter after that. In the rating firms’ projections, revenue will increase 9.60% compared to the previous financial year.
Revenue for the current quarter is expected to be $5.53 million as predicted by 5 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to $4.6 million by the end of Mar 2022. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $6.67 million and $5.43 million respectively. In this case, analysts expect current quarter sales to shrink by -17.10% and then drop by -15.30% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 19.30%. While earnings are projected to return -548.40% in 2022.
MediWound Ltd. is due to release its next quarterly earnings between February 23 and February 28. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
MediWound Ltd. (NASDAQ:MDWD)’s Major holders
MediWound Ltd. insiders own 42.80% of total outstanding shares while institutional holders control 13.87%, with the float percentage being 24.25%. ARK Investment Management, LLC is the largest shareholder of the company, while 29 institutions own stock in it. As of Sep 29, 2021, the company held over 0.76 million shares (or 2.81% of all shares), a total value of $2.55 million in shares.
The next largest institutional holding, with 0.47 million shares, is of Uniplan Investment Counsel, Inc.’s that is approximately 1.73% of outstanding shares. At the market price on Sep 29, 2021, these shares were valued at $1.58 million.
Also, the Mutual Funds coming in first place with the largest holdings of MediWound Ltd. (MDWD) shares are ARK ETF Tr-ARK Israel Innovative Technology ETF and Cavanal Hill Opportunistic Fd. Data provided on Oct 30, 2021 indicates that ARK ETF Tr-ARK Israel Innovative Technology ETF owns about 0.95 million shares. This amounts to just over 3.48 percent of the company’s overall shares, with a $3.34 million market value. The same data shows that the other fund manager holds slightly less at 0.25 million, or about 0.93% of the stock, which is worth about $0.92 million.